Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene therapies for the ...

AXPAXLI™ SOL trials for wet AMD progressing rapidly following recent updates to accelerate and enhance the registrational ...

Todd Engels, 62, from Maryland, started taking Ozempic after he saw glowing headlines and slick ads praising it as a 'miracle ...

Currently, EYLEA HD is approved for dosing intervals of 8-16 weeks for patients with wet age-related macular degeneration (wAMD) and diabetic macular edema (DME). For patients with diabetic ...

Over the first three months of 2025, Regeneron's sales from the Eylea franchise—approved in a range of retinal conditions like macular degeneration and diabetic retinopathy—fell 26% versus ...

The apparent success — and now almost ever-present ubiquity — of GLP-1 receptor agonists in weight loss has led to research, and possible uses, far beyond its initial indications in diabetes, ...

At the recent SEC meeting for Ophthalmology held on 19th March 2025, the expert panel reviewed the proposal to conduct a ...

Also, diabetic retinopathy can become temporarily worse ... It’s also important to understand Rybelsus’s label and other paperwork that may come with the drug. Colored stickers that describe ...

In a new study led by scientists at the Wilmer Eye Institute, Johns Hopkins Medicine researchers say they have determined ...

In this Healio Video Perspective from the ARVO meeting, Paolo S. Silva, MD, discusses a study comparing ultrawide field ...

Dr. David Maberley, MD, MSc. (Epid), FRCSC, Ophthalmologist, discusses diabetic retinopathy prevention and detection.